HIMS

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

Dollar change +0.41
Percentage change 0.98	%

Peers: CVS WBA TDOC AMZN JNJ UNH HUM CI PFE GDRX

| Held by: IJR IWM VTI VB IWO VXF SPSM IJT VBK SLYG

Scroll to Statements

Index	RUT	P/E	97.75	EPS (ttm)	0.43	Insider Own	18.75%	Shs Outstand	209.44M	Perf Week	32.64%
Market Cap	9.23B	Forward P/E	81.05	EPS next Y	0.52	Insider Trans	-7.84%	Shs Float	177.52M	Perf Month	58.69%
Income	101.26M	PEG	-	EPS next Q	0.10	Inst Own	56.81%	Short Float	31.87%	Perf Quarter	107.56%
Sales	1.24B	P/S	7.43	EPS this Y	592.48%	Inst Trans	9.31%	Short Ratio	3.44	Perf Half Y	136.88%
Book/sh	2.02	P/B	20.92	EPS next Y	-3.75%	ROA	19.93%	Short Interest	56.58M	Perf Year	376.42%
Cash/sh	1.16	P/C	36.34	EPS next 5Y	-	ROE	26.35%	52W Range	8.51 - 41.98	Perf YTD	74.77%
Dividend Est.	-	P/FCF	61.71	EPS past 5Y	-	ROI	22.52%	52W High	0.66%	Beta	1.39
Dividend TTM	-	Quick Ratio	1.82	Sales past 5Y	60.52%	Gross Margin	70.63%	52W Low	396.87%	ATR (14)	2.60
Dividend Ex-Date	-	Current Ratio	2.14	EPS Y/Y TTM	372.77%	Oper. Margin	2.94%	RSI (14)	82.83	Volatility	9.45% 8.13%
Employees	1046	Debt/Eq	0.03	Sales Y/Y TTM	56.70%	Profit Margin	8.15%	Recom	2.25	Target Price	28.80
Option/Short	Yes / Yes	LT Debt/Eq	0.02	EPS Q/Q	993.33%	Payout	-	Rel Volume	1.40	Prev Close	41.85
Sales Surprise	5.07%	EPS Surprise	193.88%	Sales Q/Q	77.13%	Earnings	Nov 04 AMC	Avg Volume	16.42M	Price	42.26
SMA20	35.43%	SMA50	41.14%	SMA200	97.29%	Trades		Volume	11,870,866	Change	0.98%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-10-25	Downgrade	Citigroup	Neutral → Sell	$24 → $25
Jan-07-25	Initiated	BTIG Research	Buy	$35
Dec-17-24	Initiated	Morgan Stanley	Overweight	$42
Nov-14-24	Downgrade	BofA Securities	Buy → Underperform
Aug-22-24	Initiated	Needham	Buy	$24
Aug-09-24	Downgrade	Imperial Capital	Outperform → In-line
May-22-24	Downgrade	Citigroup	Buy → Neutral	$16 → $20
Apr-16-24	Downgrade	Jefferies	Buy → Hold	$17 → $15
Apr-10-24	Initiated	Canaccord Genuity	Buy	$20
Feb-28-24	Upgrade	Imperial Capital	In-line → Outperform	$16
Feb-26-24	Initiated	Leerink Partners	Market Perform	$10
Dec-07-23	Initiated	Imperial Capital	In-line	$9
Jul-28-23	Initiated	TD Cowen	Outperform	$11
Apr-11-23	Initiated	Robert W. Baird	Neutral	$10
Feb-09-23	Upgrade	Jefferies	Hold → Buy	$7 → $11
Nov-08-22	Upgrade	SVB Leerink	Mkt Perform → Outperform	$5
Nov-08-22	Upgrade	BofA Securities	Neutral → Buy	$7.50 → $8.50
Oct-17-22	Downgrade	Piper Sandler	Overweight → Neutral	$8 → $6
Sep-07-22	Initiated	Truist	Hold	$7
Jul-15-22	Initiated	SVB Leerink	Underperform	$4

Show Previous Ratings

Feb-04-25 09:00AM	Hims & Hers Launches Health Collective and Community Member Council (Business Wire) +7.50%
Feb-03-25 04:05PM	Hims & Hers to Announce Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025 (Business Wire)
12:17PM	Hims & Hers Health Inc. (HIMS): Among The Stocks That Started The Year On A High (Insider Monkey)
Feb-02-25 04:37PM	Why Hims & Hers Health (HIMS) Is Among the Best Booming Stocks to Invest in Now? (Insider Monkey)
Feb-01-25 05:29PM	Why Hims & Hers Health (HIMS) Skyrocketed on Friday? (Insider Monkey)
06:00AM	Loading…
Jan-28-25 06:00AM	Hims & Hers to Advertise Weight-Loss Shots at the Super Bowl (The Wall Street Journal)
Jan-26-25 02:00AM	Why Hims & Hers Health, Inc. (HIMS) Is Skyrocketing Now (Insider Monkey)
Dec-19-24 04:18PM	IBD 50's Hims & Hers Tumbles After FDA Pulls Lilly's Weight-Loss Drug From Shortage List (Investor's Business Daily) -7.67%
04:03PM	Eli Lily GLP-1 shortage ends, FDA says: Hims & Hers stock falls (Yahoo Finance Video)
03:57PM	FDA finalizes decision to end Lilly's GLP-1 shortage, analysts predict Novo will be next (Yahoo Finance)
Dec-17-24 10:48AM	Tesla, crypto miners, Hims & Hers Health: Trending Tickers (Yahoo Finance Video)
Dec-12-24 09:00AM	The Shape of America 2024: Hims and Hers Shares an In-Depth Look Into How Americans Feel About Weight (Business Wire)
09:00AM	The Shape of America 2024: Hims & Hers Shares an In-Depth Look Into How Americans Feel About Weight (Business Wire)
Dec-05-24 08:00AM	The Weight-Loss Battle That Could Rattle Eli Lilly's $100 Billion Market (Investor's Business Daily) -6.84%
Dec-03-24 12:58PM	Hims and Hers Named to Inc.s 2024 Best in Business List in Health Products Category (Business Wire)
12:58PM	Loading…
12:58PM	Hims & Hers Named to Inc.s 2024 Best in Business List in Health Products Category (Business Wire)
Nov-25-24 04:14PM	Hims & Hers surges: Analysts say it's well-positioned under Trump (Yahoo Finance Video) +23.77%
Nov-21-24 12:00PM	Hims and Hers Expands Nutrition Support to Fuel Customers Weight Loss Journeys (Business Wire) +10.83%
12:00PM	Hims & Hers Expands Nutrition Support to Fuel Customers Weight Loss Journeys (Business Wire)
Nov-20-24 02:44PM	Guardant Health Stock Sees RS Rating Jump To 83 (Investor's Business Daily) -7.39%
Nov-18-24 06:00AM	Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions (Business Wire) +8.64%
Nov-17-24 04:53PM	Hims & Hers Health, Inc. (HIMS): A Bull Case Theory (Insider Monkey)
Nov-15-24 11:25AM	Netflix, Five Other Gems Soar Into Profit Zones In Hot November Rally (Investor's Business Daily) -7.34%
Nov-14-24 05:04PM	Hims & Hers Stock Drops After Amazon Says It Will Offer Hair-Loss Treatments (The Wall Street Journal) -24.46%
02:02PM	Stock Market Today: Chevron Breaks Out, But Biotechs Struggle As Eli Lilly Looks Like Short-Sale Play; Will American Airlines Break Out? (Live Coverage) (Investor's Business Daily)
Nov-13-24 09:48AM	Hims & Hers launches GLP-1 tracker in response to FDA's shortage decision (Yahoo Finance)
09:48AM	Hims & Hers launches GLP-1 shortage tracker in its battle with the FDA (Yahoo Finance)
09:15AM	Americans Continue to Struggle to Access Branded GLP-1s as Shortages Continue (Business Wire)
Nov-05-24 04:11PM	Hims Reports Strong Earnings, Novo Nordisk Copycat Drug Coming in 2025 (Investopedia) +13.47%
04:07PM	IBD 50's No. 2 Stock, Hims & Hers, Smashes Estimates On 'Robust' Obesity Trajectory (Investor's Business Daily)
12:29PM	Loading…
12:29PM	Trump vs. Harris trades, Boeing, Hims & Hers: Top Stories (Yahoo Finance Video)
11:32AM	Stocks to Watch Tuesday: Palantir, Trump Media, Super Micro, Hims (The Wall Street Journal)
Nov-04-24 07:00PM	Hims & Hers Health jumps on earnings. CFO talks GLP-1 influences. (Yahoo Finance Video)
04:05PM	Hims & Hers Health, Inc. Reports Third Quarter 2024 Financial Results (Business Wire)
Oct-29-24 09:00AM	How Compounded Treatments Are Helping Hims & Hers Customers Meet Their Weight Loss Goals (Business Wire)
Oct-27-24 11:47AM	Why compounders and telehealth providers are undeterred by the potential end of the weight-loss drug shortage (Yahoo Finance)
Oct-22-24 09:00AM	Define Ventures Appoints Bruce Broussard as Venture Partner (PR Newswire)
Oct-21-24 01:43PM	Hims & Hers Health Tops Growth 50 List As FDA OKs Cheaper Weight-Loss Drug (Investor's Business Daily)
09:00AM	Hims & Hers names Dr. Jessica Shepherd as Chief Medical Officer of Hers (Business Wire)
Oct-19-24 03:20PM	FDA not planning to take action against GLP-1 compounders, Endpoints says (TipRanks)
Oct-16-24 04:19PM	Hims & Hers Shares Rallied 22% Over Two Days. Why That Move Is Now At Risk. (Investor's Business Daily)
08:00AM	Hims & Hers Shares Have Rallied 22% This Week. Why That Move Is Now At Risk. (Investor's Business Daily)
Oct-15-24 01:04PM	Walgreens closing 1,200 stores over next 3 years, 800 more under evaluation (Yahoo Finance) +11.22%
Oct-14-24 04:25PM	Hims & Hers Stock Jumps as FDA Reconsiders Restrictions on Copycat Weight-Loss Drugs (Investopedia) +9.68%
04:06PM	Hims & Hers Health Pops After FDA Allows Compounded Copies Of Eli Lilly's Obesity Drug (Investor's Business Daily)
04:05PM	Hims & Hers to Announce Third Quarter 2024 Financial Results on November 4, 2024 (Business Wire)
03:40PM	Hims & Hers surges as FDA mulls over compounded drugs limit (Yahoo Finance Video)
Oct-10-24 04:39PM	WeightWatchers stock soars, but its cheap Wegovy knockoff 'is not a sustainable long-term business model' (Yahoo Finance)
04:39PM	WeightWatchers stock rallies 170%! But new compounded GLP-1 drug is 'not a sustainable long-term business model.' (Yahoo Finance)
04:39PM	WeightWatchers rallies 170%! But new compounded GLP-1 drug is 'not a sustainable long-term business model.' (Yahoo Finance)
Oct-04-24 06:05PM	Hims & Hers Health Set to Join S&P SmallCap 600 (PR Newswire) +10.08%
12:04PM	Eli Lilly's Mounjaro, Zepbound removed from FDA's shortage list (Yahoo Finance Video)
Oct-03-24 03:07PM	For Hims & Hers Stock, GLP-1 Giveth and GLP-1 Taketh Away (The Wall Street Journal) -9.60%
02:50PM	Stocks to Watch Thursday: Levi Strauss, Hims & Hers, Constellation Brands, Nvidia (The Wall Street Journal)
01:39PM	Hims & Hers Health Stock Falls as FDA Drops Eli Lilly Weight-Loss Drugs From Shortage List (Investopedia)
11:10AM	Hims & Hers stock falls after Eli Lilly's weight-loss drug dropped from shortage list (Yahoo Finance Video)
Sep-18-24 09:00AM	Hims & Hers to Offer Access to Compounded GLP-1 Injections for as Low as $99/Month to U.S. Military, Veterans, Teachers, Nurses and First Responders (Business Wire)
Sep-06-24 04:52PM	Why Big Pharma is betting on telehealth strategies (Yahoo Finance) -5.41%
Aug-27-24 05:15PM	Why Eli Lilly is 'the Nvidia of GLP-1' weight-loss drugs (Yahoo Finance Video) -7.54%
12:48PM	Top Stock Movers Now: Nvidia, Insulet, Paramount Global, and More (Investopedia)
11:23AM	Hims & Hers Health Stock Takes Hit as Eli Lilly Offers Cheaper Weight-Loss Drug (Investopedia)
Aug-11-24 08:09AM	What Eli Lilly, Novo Nordisk earnings reveal about the future of GLP-1 sales (Yahoo Finance)
Aug-06-24 10:34AM	Stocks to Watch Tuesday: Uber, Caterpillar, Palantir, Lucid (The Wall Street Journal) -5.38%
10:14AM	Hims & Hers Health, FuboTV, Celsius: 3 Stock in Focus (Yahoo Finance Video)
Aug-05-24 09:54PM	HIMS Stock Earnings: Hims & Hers Health Beats EPS, Beats Revenue for Q2 2024 (InvestorPlace)
05:22PM	Lucid, Hims & Hers Health, Chegg: After-hours Movers (Yahoo Finance Video)
04:05PM	Hims & Hers Health, Inc. Reports Second Quarter 2024 Financial Results (Business Wire)
03:33PM	3 Telemedicine Stocks Poised for Possible Healthcare Evolution (InvestorPlace)
Aug-01-24 07:00AM	What You Need to Know Ahead of Eli Lilly Earnings (Investopedia) -12.85%
Jul-25-24 06:00AM	Emerging Telemedicine Leaders: Stocks Shaping Healthcare's Digital Future (News Direct)
Jul-22-24 05:00AM	Pharmaceutical Industry Chief Kre Schultz Joins Hims & Hers Board (Business Wire)
Jul-15-24 04:05PM	Hims & Hers to Announce Second Quarter 2024 Financial Results on August 5, 2024 (Business Wire) +5.16%
09:45AM	3 Stocks Poised to 10X in the Next 5 Years (InvestorPlace)
Jul-12-24 09:00AM	Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Jul-08-24 12:26PM	Are Medical Stocks Lagging Hims & Hers Health (HIMS) This Year? (Zacks)
Jul-05-24 12:04PM	Hims & Hers (HIMS) Gains 37.7% in Three Months: What's Next? (Zacks)
Jun-27-24 12:31PM	Phunware (PHUN) Stock Volatile Ahead of Trump-Biden Debate Tonight (InvestorPlace) -7.14%
12:06PM	Walgreens Stores Closing: Retailer Announces Imminent' Changes as WBA Stock Slumps (InvestorPlace)
11:45AM	Hims & Hers Down Sharply Again as Scrutiny Over Ozempic Knockoff Business Grows (The Wall Street Journal)
11:28AM	Short Seller Hunterbrook Slams Hims & Hers (HIMS) Stock in New Report (InvestorPlace)
03:24AM	Heard on the Street Wednesday Recap: Land of the Rising Sum (The Wall Street Journal)
Jun-26-24 07:00AM	The War Over Cheaper Ozempic Wont End Well for Some Investors (The Wall Street Journal) -6.91%
Jun-24-24 05:45PM	Hims & Hers Health, Inc. (HIMS) Flat As Market Sinks: What You Should Know (Zacks)
Jun-19-24 09:00AM	Here is What to Know Beyond Why Hims & Hers Health, Inc. (HIMS) is a Trending Stock (Zacks)
Jun-17-24 05:45PM	Hims & Hers Health, Inc. (HIMS) Outpaces Stock Market Gains: What You Should Know (Zacks)
Jun-11-24 05:45PM	Hims & Hers Health, Inc. (HIMS) Outpaces Stock Market Gains: What You Should Know (Zacks) +7.44%
Jun-07-24 09:00AM	Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know (Zacks)
May-27-24 09:00AM	Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
May-24-24 04:37PM	The Score: Target, Nvidia, Live Nation and More Stocks That Defined the Week (The Wall Street Journal) +6.63% +13.15%
09:28AM	7 Stocks to Dominate in the Next Economic Upturn (InvestorPlace)
May-23-24 06:50AM	Move Over Ozempic! 3 New GLP-1 Drugs and Products Coming Soon. (InvestorPlace)
May-22-24 06:05PM	Nvidia earnings, housing market outlook, BNPL regulatory pressure: Market Domination (Yahoo Finance Video) -7.92%
04:23PM	Citigroup downgrades Hims & Hers Health to Neutral from Buy (Yahoo Finance Video)
12:42PM	The Growth Stock Shuffle: 2 to Ditch and 1 to Own (InvestorPlace)
May-21-24 07:30AM	Lowes, Macys report, crypto surges: Yahoo Finance (Yahoo Finance Video) -5.59%
May-20-24 04:29PM	Hims & Hers Health Stock Jumps Nearly 28% on Plans to Offer GLP-1 Weight-Loss Drugs (Investopedia) +27.66%
03:16PM	HIMS Stock Alert: Hims & Hers Shares Rocket on Weight Loss Injections (InvestorPlace)
02:47PM	Top Stock Movers Now: Jabil, Norwegian Cruise Line, Hims & Hers Health, and More (Investopedia)
01:05PM	Investors await Nvidia earnings, commodities on the rise: Morning Brief (Yahoo Finance Video)
01:04PM	Investors eye chip stocks, Palo Alto Networks earnings on tap: Yahoo Finance (Yahoo Finance Video)

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Dudum Andrew	Chief Executive Officer	Jan 31 '25	Option Exercise	2.43	100,000	243,000	127,918	Feb 04 04:26 PM
Dudum Andrew	Chief Executive Officer	Jan 31 '25	Sale	35.22	100,000	3,522,300	27,918	Feb 04 04:26 PM
Boughton Soleil	Chief Legal Officer	Feb 03 '25	Sale	35.30	4,153	146,601	161,497	Feb 04 04:25 PM
Chi Michael	Chief Commercial Officer	Feb 03 '25	Option Exercise	11.53	2,054	23,683	195,655	Feb 04 04:25 PM
Chi Michael	Chief Commercial Officer	Feb 03 '25	Sale	35.30	2,054	72,506	193,601	Feb 04 04:25 PM
Boughton Soleil	Officer	Feb 03 '25	Proposed Sale	35.30	4,153	146,601		Feb 03 11:11 AM
Chi Michael	Officer	Feb 03 '25	Proposed Sale	35.30	2,054	72,506		Feb 03 11:11 AM
Dudum Andrew	Officer	Jan 31 '25	Proposed Sale	35.22	100,000	3,522,297		Jan 31 10:43 AM
Chi Michael	Chief Commercial Officer	Jan 24 '25	Option Exercise	5.01	17,304	86,693	210,905	Jan 24 05:20 PM
Chi Michael	Chief Commercial Officer	Jan 24 '25	Sale	31.00	17,304	536,424	193,601	Jan 24 05:20 PM
Dudum Andrew	Chief Executive Officer	Jan 23 '25	Option Exercise	2.43	27,098	65,848	55,016	Jan 24 05:20 PM
Dudum Andrew	Chief Executive Officer	Jan 23 '25	Sale	30.08	27,098	815,029	27,918	Jan 24 05:20 PM
Chi Michael	Officer	Jan 24 '25	Proposed Sale	31.00	17,304	536,424		Jan 24 09:53 AM
Boughton Soleil	Chief Legal Officer	Jan 21 '25	Option Exercise	5.01	50,000	250,500	219,803	Jan 23 04:32 PM
Boughton Soleil	Chief Legal Officer	Jan 21 '25	Sale	29.90	54,153	1,619,108	165,650	Jan 23 04:32 PM
Baird Melissa	Chief Operating Officer	Jan 21 '25	Option Exercise	0.40	67,687	27,075	774,559	Jan 23 04:32 PM
Baird Melissa	Chief Operating Officer	Jan 21 '25	Sale	29.35	67,687	1,986,731	706,872	Jan 23 04:32 PM
Chi Michael	Chief Commercial Officer	Jan 21 '25	Option Exercise	13.90	306	4,253	193,907	Jan 23 04:32 PM
Chi Michael	Chief Commercial Officer	Jan 21 '25	Sale	28.68	306	8,776	193,601	Jan 23 04:32 PM
Dudum Andrew	Chief Executive Officer	Jan 22 '25	Option Exercise	2.43	14,269	34,674	42,187	Jan 23 04:32 PM
Dudum Andrew	Chief Executive Officer	Jan 21 '25	Option Exercise	2.43	300	729	28,218	Jan 23 04:32 PM
Dudum Andrew	Chief Executive Officer	Jan 22 '25	Sale	30.08	14,269	429,184	27,918	Jan 23 04:32 PM
Dudum Andrew	Chief Executive Officer	Jan 21 '25	Sale	30.00	300	9,000	27,918	Jan 23 04:32 PM
Dudum Andrew	Officer	Jan 23 '25	Proposed Sale	30.08	27,098	815,030		Jan 23 12:55 PM
Dudum Andrew	Officer	Jan 22 '25	Proposed Sale	30.08	14,269	429,184		Jan 22 04:24 PM
Melissa Baird	Officer	Jan 21 '25	Proposed Sale	29.81	67,687	2,017,749		Jan 21 04:55 PM
Dudum Andrew	Officer	Jan 21 '25	Proposed Sale	30.00	300	9,000		Jan 21 04:54 PM
Boughton Soleil	Officer	Jan 21 '25	Proposed Sale	29.90	54,153	1,619,108		Jan 21 04:32 PM
Dudum Andrew	Chief Executive Officer	Jan 16 '25	Option Exercise	2.43	33,668	81,813	64,378	Jan 21 04:13 PM
Dudum Andrew	Chief Executive Officer	Jan 16 '25	Sale	27.01	47,534	1,283,884	475,330	Jan 21 04:13 PM
Dudum Andrew	Chief Executive Officer	Jan 16 '25	Sale	27.09	36,460	987,529	27,918	Jan 21 04:13 PM
Chi Michael	Officer	Jan 21 '25	Proposed Sale	28.68	306	8,776		Jan 21 10:16 AM
Dudum Andrew	Officer	Jan 16 '25	Proposed Sale	27.04	83,994	2,271,414		Jan 16 12:40 PM
Okupe Oluyemi	Chief Financial Officer	Jan 13 '25	Option Exercise	5.01	6,437	32,249	129,658	Jan 14 04:31 PM
Okupe Oluyemi	Chief Financial Officer	Jan 13 '25	Sale	24.44	11,581	283,083	118,077	Jan 14 04:31 PM
Chi Michael	Chief Commercial Officer	Jan 10 '25	Option Exercise	6.82	7,259	49,506	200,860	Jan 14 04:31 PM
Chi Michael	Chief Commercial Officer	Jan 10 '25	Sale	24.07	7,259	174,724	193,601	Jan 14 04:31 PM
Chi Michael	Officer	Jan 10 '25	Proposed Sale	24.07	7,259	174,724		Jan 10 10:39 AM
Boughton Soleil	Chief Legal Officer	Jan 06 '25	Option Exercise	3.85	254,023	979,134	438,735	Jan 07 04:48 PM
Boughton Soleil	Chief Legal Officer	Jan 06 '25	Sale	27.75	268,932	7,463,195	169,803	Jan 07 04:48 PM
Okupe Oluyemi	Chief Financial Officer	Jan 02 '25	Option Exercise	5.01	6,437	32,249	134,802	Jan 06 04:40 PM
Okupe Oluyemi	Chief Financial Officer	Jan 02 '25	Sale	24.68	11,581	285,784	123,221	Jan 06 04:40 PM
Chi Michael	Chief Commercial Officer	Jan 02 '25	Option Exercise	11.53	2,055	23,694	195,656	Jan 06 04:39 PM
Chi Michael	Chief Commercial Officer	Jan 02 '25	Sale	24.62	2,055	50,594	193,601	Jan 06 04:39 PM
Boughton Soleil	Officer	Jan 06 '25	Proposed Sale	27.75	268,932	7,463,195		Jan 06 01:05 PM
Chi Michael	Officer	Jan 02 '25	Proposed Sale	24.62	2,055	50,594		Jan 02 10:51 AM
Baird Melissa	Chief Operating Officer	Dec 27 '24	Option Exercise	4.56	31,518	143,669	706,872	Dec 30 04:22 PM
Okupe Oluyemi	Chief Financial Officer	Dec 26 '24	Sale	29.98	4,213	126,318	128,365	Dec 27 04:48 PM
Chi Michael	Chief Commercial Officer	Dec 24 '24	Option Exercise	5.01	17,303	86,688	210,904	Dec 27 04:47 PM
Chi Michael	Chief Commercial Officer	Dec 24 '24	Sale	27.97	17,303	483,965	193,601	Dec 27 04:47 PM
Chi Michael	Officer	Dec 24 '24	Proposed Sale	27.97	17,303	483,965		Dec 26 08:51 AM
Chi Michael	Chief Commercial Officer	Dec 19 '24	Option Exercise	13.90	7,500	104,250	201,101	Dec 23 04:40 PM
Chi Michael	Chief Commercial Officer	Dec 19 '24	Sale	26.00	7,500	195,000	193,601	Dec 23 04:40 PM
Okupe Oluyemi	Chief Financial Officer	Dec 20 '24	Sale	25.77	18,959	488,531	132,578	Dec 23 04:40 PM
Oluyemi Okupe	Officer	Dec 20 '24	Proposed Sale	26.20	69,496	1,820,795		Dec 20 04:34 PM
Chi Michael	Officer	Dec 19 '24	Proposed Sale	26.00	7,500	195,000		Dec 19 10:13 AM
Chi Michael	Chief Commercial Officer	Dec 17 '24	Sale	32.20	25,550	822,710	193,601	Dec 17 07:03 PM
Becklund Irene	PAO	Dec 16 '24	Option Exercise	9.41	472	4,442	17,803	Dec 17 07:02 PM
Becklund Irene	PAO	Dec 17 '24	Sale	32.20	10,012	322,386	7,319	Dec 17 07:02 PM
Becklund Irene	PAO	Dec 16 '24	Sale	29.58	472	13,962	17,331	Dec 17 07:02 PM
Dudum Andrew	Chief Executive Officer	Dec 16 '24	Option Exercise	2.43	75,335	183,064	151,623	Dec 17 07:01 PM
Dudum Andrew	Chief Executive Officer	Dec 17 '24	Sale	32.09	79,246	2,543,119	30,710	Dec 17 07:01 PM
Dudum Andrew	Chief Executive Officer	Dec 16 '24	Sale	29.62	78,127	2,314,196	109,956	Dec 17 07:01 PM
Dudum Andrew	Chief Executive Officer	Dec 16 '24	Sale	29.18	47,534	1,386,968	522,864	Dec 17 07:01 PM
Dudum Andrew	Officer	Dec 17 '24	Proposed Sale	32.09	79,246	2,543,119		Dec 17 01:54 PM
Becklund Irene	Officer	Dec 17 '24	Proposed Sale	32.20	10,012	322,386		Dec 17 10:52 AM
Chi Michael	Officer	Dec 17 '24	Proposed Sale	32.20	25,550	822,710		Dec 17 10:13 AM
Dudum Andrew	Officer	Dec 16 '24	Proposed Sale	29.45	125,661	3,701,163		Dec 16 02:19 PM
Becklund Irene	Officer	Dec 16 '24	Proposed Sale	29.58	472	13,962		Dec 16 11:00 AM
Chi Michael	Chief Commercial Officer	Dec 10 '24	Option Exercise	6.82	7,259	49,506	192,206	Dec 12 05:02 PM
Chi Michael	Chief Commercial Officer	Dec 10 '24	Sale	32.25	7,259	234,103	184,947	Dec 12 05:02 PM
Baird Melissa	Chief Operating Officer	Dec 10 '24	Option Exercise	0.40	85,561	34,224	716,547	Dec 12 05:02 PM
Baird Melissa	Chief Operating Officer	Dec 10 '24	Sale	31.01	85,561	2,653,129	630,986	Dec 12 05:02 PM
Melissa Baird	Officer	Dec 10 '24	Proposed Sale	30.87	85,561	2,641,268		Dec 10 04:35 PM
Chi Michael	Officer	Dec 10 '24	Proposed Sale	32.25	7,259	234,103		Dec 10 10:26 AM
Chi Michael	Chief Commercial Officer	Dec 02 '24	Option Exercise	11.53	2,054	23,683	187,001	Dec 03 04:26 PM
Chi Michael	Chief Commercial Officer	Dec 02 '24	Sale	33.56	2,054	68,932	184,947	Dec 03 04:26 PM
Dudum Andrew	Chief Executive Officer	Dec 02 '24	Sale	33.38	33,513	1,118,654	33,502	Dec 03 04:25 PM
Chi Michael	Officer	Dec 02 '24	Proposed Sale	33.56	2,054	68,932		Dec 02 01:41 PM
Dudum Andrew	Officer	Dec 02 '24	Proposed Sale	33.38	33,513	1,118,655		Dec 02 01:32 PM
Boughton Soleil	Chief Legal Officer	Nov 26 '24	Sale	29.90	2,343	70,056	165,254	Nov 26 06:32 PM
Okupe Oluyemi	Chief Financial Officer	Nov 25 '24	Option Exercise	5.01	97,776	489,858	209,962	Nov 26 06:32 PM
Okupe Oluyemi	Chief Financial Officer	Nov 25 '24	Sale	29.62	101,993	3,021,496	109,392	Nov 26 06:32 PM
Chi Michael	Chief Commercial Officer	Nov 25 '24	Option Exercise	5.01	17,303	86,688	201,283	Nov 26 06:32 PM
Chi Michael	Chief Commercial Officer	Nov 25 '24	Sale	26.49	17,303	458,356	184,947	Nov 26 06:32 PM
Boughton Soleil	Officer	Nov 26 '24	Proposed Sale	29.90	2,343	70,056		Nov 26 09:45 AM
Chi Michael	Officer	Nov 25 '24	Proposed Sale	26.49	17,303	458,356		Nov 25 12:20 PM
Chi Michael	Chief Commercial Officer	Nov 19 '24	Option Exercise	13.90	7,500	104,250	191,480	Nov 19 07:23 PM
Chi Michael	Chief Commercial Officer	Nov 19 '24	Sale	22.00	7,500	165,000	183,980	Nov 19 07:23 PM
Baird Melissa	Chief Operating Officer	Nov 18 '24	Option Exercise	0.40	58,750	23,500	688,916	Nov 19 06:08 PM
Baird Melissa	Chief Operating Officer	Nov 18 '24	Sale	21.04	58,750	1,236,364	630,166	Nov 19 06:08 PM
Becklund Irene	PAO	Nov 18 '24	Option Exercise	9.41	472	4,442	5,588	Nov 19 06:08 PM
Becklund Irene	PAO	Nov 18 '24	Sale	19.42	472	9,166	5,116	Nov 19 06:08 PM
Chi Michael	Officer	Nov 19 '24	Proposed Sale	22.00	7,500	165,000		Nov 19 01:50 PM
Melissa Baird	Officer	Nov 18 '24	Proposed Sale	20.99	58,750	1,233,162		Nov 18 05:15 PM
Becklund Irene	Officer	Nov 18 '24	Proposed Sale	19.42	472	9,166		Nov 18 11:46 AM
Manuel Anja	Director	Nov 12 '24	Buy	26.94	4,000	107,760	4,000	Nov 14 04:57 PM
Manuel Anja	Director	Nov 14 '24	Buy	24.50	1,000	24,500	5,000	Nov 14 04:57 PM
Okupe Oluyemi	Chief Financial Officer	Nov 13 '24	Option Exercise	6.57	109,309	717,810	255,072	Nov 14 04:57 PM
Okupe Oluyemi	Chief Financial Officer	Nov 13 '24	Sale	29.93	142,886	4,276,609	112,186	Nov 14 04:57 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Hims & Hers Health Inc

Upgrade your FINVIZ experience